Materiality pending
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
- Merit Medical's quarterly earnings beat estimates at $0.77 per share, adjusted for non-recurring items. - Revenues for the quarter ended March 2024 were $323.51 million, surpassing estimates by 2.40%. - Merit Medical's stock has lost 1.2% YTD vs. S&P 500's gain of 7.3%. - Estimate revisions trend for Merit Medical is favorable, currently at a Zacks Rank #2. - Industry outlook can also impact stock performance; Medical - Dental Supplies in the top 34%. Price Impact Rating: bullish Impact Horizon Rating: short-term Type: Earnings
- Merit Medical's quarterly earnings beat estimates at $0.77 per share, adjusted for non-recurring items.
- Revenues for the quarter ended March 2024 were $323.51 million, surpassing estimates by 2.40%.
- Merit Medical's stock has lost 1.2% YTD vs. S&P 500's gain of 7.3%.
- Estimate revisions trend for Merit Medical is favorable, currently at a Zacks Rank #2.
- Industry outlook can also impact stock performance; Medical - Dental Supplies in the top 34%.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.